Health · 13 Nov
HIV | హెచ్ఐవీ వ్యాధిగ్రస్తులకు కొత్త ఔషధం.. ఏడాదికి రెండుసార్లు ఇంజెక్షన్ చాలు..
AI summaryThe article discusses the development of Lenacapavir, a new long-acting injectable HIV prevention drug, and its potential to protect against the virus with biannual injections. It highlights the high demand for the drug in Uganda's Bwera region, where HIV prevalence is high, and notes that while generic versions have received temporary approval in the US for low-income countries, current supply shortages prevent widespread distribution.
1 outlet